Recent policies provide detailed instruction to promote the implementation of preferential policies of high-value drugs. Noteworthy policy items include:

  • President Xi emphasized promoting a Comprehensive Regulatory System of Healthcare at the second meeting of the Central Leading Committee for Comprehensively Deepening Reform
  • State Council released Plans for Deepening Reforms and Opening up in Free Trade Pilot Zones of Fujian, Tianjin, and Guangdong
  • SDA and NHC released Announcement Regarding Optimizing Several Issues within the Drug Registration and Approval Process
  • NHC released the first Catalog of Rare Diseases and the Working Procedure for the Formulation of the Catalog

The latest issue could be downloaded Here.

Leave a comment